EndoCure turns a standard ultrasound into a robotic, AI-driven scanner
The Seed-stage HealthTech company, which aims to deliver MRI-like detail from operator-independent ultrasound scans, joins ScaleUp House's inaugural cohort.
EndoCure is one of the companies selected for the inaugural ScaleUp House cohort, joining the year-round program as it enters its next stage of international growth. The company develops Revealan, a platform that adds robotic scanning and diagnostic AI to standard ultrasound systems to automate and standardize scans, with a focus on expanding its presence in global markets and building the foundations for its next phase of growth.
ID card
Name: EndoCure
Industry: MedTech / HealthTech
Current Stage: Seed
Founder Name: Hadas Ziso
Year Founded: 2023
Number of Employees: 4
Company Description
EndoCure is a HealthTech startup that turns standard ultrasound systems into automated, AI-powered diagnostic platforms. Its flagship product, Revealan, combines robotic scanning, physical AI, high-density 3D imaging and diagnostic AI to produce standardized, operator-independent scans, which the company says offer MRI-like insight at a fraction of the cost. By covering the imaging workflow from image acquisition through clinical decision support, EndoCure aims to enable earlier detection, more accurate diagnosis and better follow-up, and to widen access to advanced imaging.
